PRECISION NEO-STIM
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Nov 2023)
What this means for you
This application is over — abandoned 20 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88874227
- Mark type
- Stylized text
- Filed
- 16 Apr 2020
- Published for opposition
- 23 Feb 2021
- Abandoned
- 20 Nov 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids
Owner
- BIONTECH US INC., Cambridge, MA, US
- BIONTECH US INC., DOVER, DE, US
- Neon Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 20 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2023 — SOU EXTENSION 4 GRANTED
- 02 Mar 2023 — SOU EXTENSION 4 FILED
- 02 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 01 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Sept 2022 — CORRECTED NOA E-MAILED
- 31 Aug 2022 — SOU EXTENSION 3 GRANTED
- 11 Aug 2022 — SOU EXTENSION 3 FILED
- 31 Aug 2022 — DIVISIONAL PROCESSING COMPLETE
- 11 Aug 2022 — DIVISIONAL REQUEST RECEIVED
- 31 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Aug 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 11 Aug 2022 — SOU TEAS EXTENSION RECEIVED